Table of Content

1. Executive Summary
1.1. Global Primary Care POC Diagnostics Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Global Primary Care POC Diagnostics Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Primary Care POC Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2019-2026
3.3. Global Primary Care POC Diagnostics Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019 - 2023
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2024 - 2031
3.3.3.1. Glucose Testing
3.3.3.2. Hb1Ac Testing
3.3.3.3. Autoimmune Disease
3.3.3.4. Coagulation
3.3.3.5. Fertility
3.3.3.6. Infectious Diseases
3.3.3.7. Cardiac Markers
3.3.3.8. Thyroid Stimulating Hormone
3.3.3.9. Hematology
3.3.3.10. Primary Care Systems
3.3.3.11. Decentralized Clinical Chemistry
3.3.3.12. Feces
3.3.3.13. Lipid Testing
3.3.3.14. Cancer Marker
3.3.3.15. Blood Gas/Electrolytes
3.3.3.16. Ambulatory Chemistry
3.3.3.17. Drug Abuse Testing
3.3.3.18. Urinalysis
3.4. Market Attractiveness Analysis: Product
3.5. Global Primary Care POC Diagnostics Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
3.5.3.1. Pharmacy & Retail Clinics
3.5.3.2. Physician Office
3.5.3.3. Urgent Care Clinics
3.5.3.4. Non-practice Clinics
3.6. Market Attractiveness Analysis: End User
4. Global Primary Care POC Diagnostics Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024 - 2031
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Global Primary Care POC Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
5.3.1. By Country
5.3.2. By Product
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2024 - 2031
5.5.1. Glucose Testing
5.5.2. Hb1Ac Testing
5.5.3. Autoimmune Disease
5.5.4. Coagulation
5.5.5. Fertility
5.5.6. Infectious Diseases
5.5.7. Cardiac Markers
5.5.8. Thyroid Stimulating Hormone
5.5.9. Hematology
5.5.10. Primary Care Systems
5.5.11. Decentralized Clinical Chemistry
5.5.12. Feces
5.5.13. Lipid Testing
5.5.14. Cancer Marker
5.5.15. Blood Gas/Electrolytes
5.5.16. Ambulatory Chemistry
5.5.17. Drug Abuse Testing
5.5.18. Urinalysis
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
5.6.1. Pharmacy & Retail Clinics
5.6.2. Physician Office
5.6.3. Urgent Care Clinics
5.6.4. Non-practice Clinics
5.7. Market Attractiveness Analysis
6. Europe Global Primary Care POC Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
6.3.1. By Country
6.3.2. By Product
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2024 - 2031
6.5.1. Glucose Testing
6.5.2. Hb1Ac Testing
6.5.3. Autoimmune Disease
6.5.4. Coagulation
6.5.5. Fertility
6.5.6. Infectious Diseases
6.5.7. Cardiac Markers
6.5.8. Thyroid Stimulating Hormone
6.5.9. Hematology
6.5.10. Primary Care Systems
6.5.11. Decentralized Clinical Chemistry
6.5.12. Feces
6.5.13. Lipid Testing
6.5.14. Cancer Marker
6.5.15. Blood Gas/Electrolytes
6.5.16. Ambulatory Chemistry
6.5.17. Drug Abuse Testing
6.5.18. Urinalysis
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
6.6.1. Pharmacy & Retail Clinics
6.6.2. Physician Office
6.6.3. Urgent Care Clinics
6.6.4. Non-practice Clinics
6.7. Market Attractiveness Analysis
7. East Asia Global Primary Care POC Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
7.3.1. By Country
7.3.2. By Product
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2024 - 2031
7.5.1. Glucose Testing
7.5.2. Hb1Ac Testing
7.5.3. Autoimmune Disease
7.5.4. Coagulation
7.5.5. Fertility
7.5.6. Infectious Diseases
7.5.7. Cardiac Markers
7.5.8. Thyroid Stimulating Hormone
7.5.9. Hematology
7.5.10. Primary Care Systems
7.5.11. Decentralized Clinical Chemistry
7.5.12. Feces
7.5.13. Lipid Testing
7.5.14. Cancer Marker
7.5.15. Blood Gas/Electrolytes
7.5.16. Ambulatory Chemistry
7.5.17. Drug Abuse Testing
7.5.18. Urinalysis
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
7.6.1. Pharmacy & Retail Clinics
7.6.2. Physician Office
7.6.3. Urgent Care Clinics
7.6.4. Non-practice Clinics
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Global Primary Care POC Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
8.3.1. By Country
8.3.2. By Product
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2024 - 2031
8.5.1. Glucose Testing
8.5.2. Hb1Ac Testing
8.5.3. Autoimmune Disease
8.5.4. Coagulation
8.5.5. Fertility
8.5.6. Infectious Diseases
8.5.7. Cardiac Markers
8.5.8. Thyroid Stimulating Hormone
8.5.9. Hematology
8.5.10. Primary Care Systems
8.5.11. Decentralized Clinical Chemistry
8.5.12. Feces
8.5.13. Lipid Testing
8.5.14. Cancer Marker
8.5.15. Blood Gas/Electrolytes
8.5.16. Ambulatory Chemistry
8.5.17. Drug Abuse Testing
8.5.18. Urinalysis
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
8.6.1. Pharmacy & Retail Clinics
8.6.2. Physician Office
8.6.3. Urgent Care Clinics
8.6.4. Non-practice Clinics
8.7. Market Attractiveness Analysis
9. Latin America Global Primary Care POC Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2024 - 2031
9.5.1. Glucose Testing
9.5.2. Hb1Ac Testing
9.5.3. Autoimmune Disease
9.5.4. Coagulation
9.5.5. Fertility
9.5.6. Infectious Diseases
9.5.7. Cardiac Markers
9.5.8. Thyroid Stimulating Hormone
9.5.9. Hematology
9.5.10. Primary Care Systems
9.5.11. Decentralized Clinical Chemistry
9.5.12. Feces
9.5.13. Lipid Testing
9.5.14. Cancer Marker
9.5.15. Blood Gas/Electrolytes
9.5.16. Ambulatory Chemistry
9.5.17. Drug Abuse Testing
9.5.18. Urinalysis
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
9.6.1. Pharmacy & Retail Clinics
9.6.2. Physician Office
9.6.3. Urgent Care Clinics
9.6.4. Non-practice Clinics
9.7. Market Attractiveness Analysis
10. Middle East & Africa Global Primary Care POC Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2024 - 2031
10.5.1. Glucose Testing
10.5.2. Hb1Ac Testing
10.5.3. Autoimmune Disease
10.5.4. Coagulation
10.5.5. Fertility
10.5.6. Infectious Diseases
10.5.7. Cardiac Markers
10.5.8. Thyroid Stimulating Hormone
10.5.9. Hematology
10.5.10. Primary Care Systems
10.5.11. Decentralized Clinical Chemistry
10.5.12. Feces
10.5.13. Lipid Testing
10.5.14. Cancer Marker
10.5.15. Blood Gas/Electrolytes
10.5.16. Ambulatory Chemistry
10.5.17. Drug Abuse Testing
10.5.18. Urinalysis
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
10.6.1. Pharmacy & Retail Clinics
10.6.2. Physician Office
10.6.3. Urgent Care Clinics
10.6.4. Non-practice Clinics
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2023
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Roche Diagnostics
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. BD Biosciences
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Danaher Corporation
11.3.3.1. \ Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Abbott Laboratories
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Instrumentation Laboratory
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. bioMerieux
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Siemens Healthcare
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Quidel Corporation
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations